Riskpilot← Back to searchSign inGet full accessFØFLEKKLINIKKEN AS
ASActiveOrg 912161064Lindbäckveien 9D, 1163 OsloGeneral medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
NOK 43K
+1% vs 2023
EBITDA margin
-88.0%
-293% vs 2023
Equity ratio
99.4%
Financial strength
Net profit 2024
NOK -8K
-125% vs 2023
| Revenue | NOK 43K | +1% |
| EBITDA | NOK -38K | -293% |
| Net profit | NOK -8K | -125% |
| Total assets | NOK 945K | -6% |
| Equity | NOK 939K | -1% |
| Employees | 0 | — |
Legal name
FØFLEKKLINIKKEN AS
Org number
912161064
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. august 2013
Share capital
NOK 31 664
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å tilby legetjenester, legemiddelutprøving og andre tjenester relatert til fagområdet.
Address
Lindbäckveien 9D, 1163 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 760 | 1 604 | 717 | 42 | 43 |
| Staff expenses | −110 | −101 | 9 | −0 | −73 |
| EBITDA | 1 296 | 145 | 561 | 20 | −38 |
| Depreciation & amort. | −23 | −25 | −14 | −0 | −0 |
| EBIT | 1 273 | 121 | 547 | 20 | −38 |
| Net financials | 248 | 673 | −32 | 23 | 27 |
| Profit before tax | 1 521 | 794 | 515 | 42 | −11 |
| Tax | 305 | 29 | 123 | 10 | −2 |
| Net profit | 1 216 | 765 | 392 | 33 | −8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 732 | 7 212 | 1 081 | 1 002 | 945 |
| Equity | 6 389 | 7 154 | 945 | 947 | 939 |
| Long-term debt | 19 | 13 | 13 | 8 | 6 |
| Short-term debt | 323 | 44 | 123 | 47 | 0 |
| Total debt | 343 | 58 | 136 | 55 | 6 |
EBITDA margin
-88.0%
This company
15.8%
Market median
-657% vs market
20202024
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
-0.9%
This company
18.4%
Market median
-105% vs market
20202024
Net profit margin
-19.2%
This company
8.1%
Market median
-337% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SD Chief Executive Officer | Chief Executive Officer | 2025 |
SN Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FØFLEKKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanna Danielsen Nasrala | Chief Executive Officer | 0 companies |
| Samuel Nasrala | Chief Executive Officer | 0 companies |
| Bernard Adeeb Danielsen Nasrala | Board of Directors | 0 companies |
| Marianne Stephanie Nasrala Hjelle | Chairman | 0 companies |
| Pierre Paul Skarstøl Nasrala | Board of Directors | 0 companies |
| Martin Nasrala Hjelle | Board of Directors | 0 companies |
| Marit Skarstøl Nasrala | Board of Directors | 0 companies |